Eli Lilly's Mounjaro has seen explosive growth since its March launch in India, with sales soaring to Rs 50 crore in three ...

AFTER ditching Mounjaro for two weeks to go on holiday, a mother has shared what really happens when you stop taking fat jabs ...

NEW YORK (Reuters) -WeightWatchers will announce on Tuesday Dr. Kim Boyd as its chief medical officer, and plans for a new program to help women manage the transition into menopause and beyond, part ...

H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...

There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some unsightly downsides such as tooth decay, a droopy face or mouth, a saggy butt ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

Popular weight loss drugs like Ozempic and Mounjaro are now linked to rare but serious cases of acute pancreatitis, including ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – ...